Inactivated Vaccines

A Global Strategic Business Report

MCP33962

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7146

EXECUTIVE POOL

5850

PRICE

814

EXPERT INPUTS

36

COMPANIES

402

DATA TABLES

468

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Inactivated Vaccines Market to Reach US$54.1 Billion by 2030

The global market for Inactivated Vaccines estimated at US$41.6 Billion in the year 2024, is expected to reach US$54.1 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Viral Vaccine Type, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$35.3 Billion by the end of the analysis period. Growth in the Bacterial Vaccine Type segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.3 Billion While China is Forecast to Grow at 8.3% CAGR

The Inactivated Vaccines market in the U.S. is estimated at US$11.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Inactivated Vaccines Market – Key Trends & Drivers Summarized

How Do Inactivated Vaccines Maintain Their Relevance in a Rapidly Evolving Immunization Landscape?
Inactivated vaccines, which contain pathogens that have been killed through chemical or physical processes, continue to serve as a cornerstone of global immunization efforts due to their robust safety profile and broad applicability. Unlike live-attenuated vaccines, inactivated formulations pose no risk of reversion to virulence, making them especially critical for immunocompromised individuals, the elderly, and pregnant women. These vaccines are widely used for diseases such as hepatitis A, rabies, polio (IPV), Japanese encephalitis, and influenza, with emerging relevance in pandemic preparedness scenarios.

Their non-replicating nature means booster doses are often required, yet this trade-off is balanced by their ability to induce strong humoral immune responses with well-understood safety parameters. Governments and global health agencies continue to prioritize inactivated vaccines in their procurement strategies, particularly in regions where cold chain stability, regulatory acceptance, and public trust in vaccine safety are high priorities. Moreover, the role of inactivated vaccines in combination formulations—particularly in pediatric immunization schedules—is reinforcing their relevance across global markets.

What Technological Innovations Are Reshaping the Development and Delivery of Inactivated Vaccines?
A wave of innovation is enhancing the scalability, purity, and immunogenicity of inactivated vaccine platforms. Cell culture-based production methods, such as Vero and MDCK cell lines, are replacing traditional egg-based and animal-derived substrates, resulting in safer and more consistent manufacturing. These platforms are particularly useful for producing vaccines against polio, influenza, and rabies. Moreover, novel adjuvants like aluminum salts, MF59, and AS03 are being incorporated to amplify immune responses and reduce the number of required doses.

Another critical advancement is the development of thermostable and lyophilized formulations, which are designed to maintain potency in high-temperature or low-resource settings. This is especially important in rural regions of Africa and Southeast Asia where cold chain logistics are difficult to maintain. In addition, digital tracking systems and smart packaging technologies are being integrated to ensure proper storage, traceability, and usage compliance. These improvements are not only optimizing vaccine logistics but also supporting global mass immunization campaigns, particularly during emergencies like pandemics or sudden disease outbreaks.

Which Disease Targets and Geographies Are Fueling Demand for Inactivated Vaccines?
Demand for inactivated vaccines is particularly strong in pediatric immunization programs and in infectious disease control initiatives across Asia-Pacific, Latin America, and parts of Africa. IPV is increasingly replacing oral polio vaccines as countries move into the final stages of polio eradication, while inactivated rabies vaccines are crucial in managing post-exposure prophylaxis in endemic countries. Seasonal influenza vaccination, which often relies on inactivated quadrivalent formulations, remains a major growth segment in North America and Europe, especially in aging populations and those with chronic diseases.

Emerging infectious threats such as COVID-19 have also reignited global interest in inactivated vaccine platforms. Several COVID-19 vaccines developed using traditional inactivation methods have been deployed at scale in countries like China, India, and the UAE, showcasing the speed and scalability of this platform in crisis response. Additionally, zoonotic threats such as avian influenza and tick-borne encephalitis are further driving the development and deployment of inactivated vaccines for both human and veterinary applications. Public-private partnerships are supporting local manufacturing in lower-income nations, ensuring more equitable access to these vaccines across geographic and economic divides.

The Growth in the Inactivated Vaccines Market Is Driven by Several Factors…
It is driven by the increasing global focus on vaccine safety, particularly for use in vulnerable populations and immunocompromised individuals. Technological advancements in cell culture production and adjuvant development are improving the efficiency, potency, and scalability of inactivated vaccines, making them more suitable for both routine and emergency immunization campaigns. The rising prevalence of zoonotic diseases and emerging pandemics is also accelerating demand for flexible and rapid-response vaccine platforms, in which inactivated vaccines have proven critical.

Additionally, policy shifts such as the transition from OPV to IPV in polio-endemic and transitioning countries are expanding the adoption base of inactivated formulations. Government-supported programs in rabies control, hepatitis A prevention, and pandemic influenza preparedness are further bolstering market growth, supported by Gavi, WHO, and regional health alliances. Increasing uptake of combination pediatric vaccines, including IPV and other inactivated components, is streamlining immunization schedules and improving compliance. The expansion of vaccine manufacturing infrastructure in developing regions, supported by technology transfer and international funding, is helping to reduce production costs and improve global supply security—further fueling the sustained growth of the inactivated vaccines market.

SCOPE OF STUDY

The report analyzes the Inactivated Vaccines market by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Viral Vaccine Type, Bacterial Vaccine Type); Inactivation Method (Solvent Detergent Method, Radiation Method, pH Concentration, Other Inactivation Methods); Administration Route (Oral, Subcutaneous, Intravenous); End-User (Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User, Other End-Users).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Astellas Pharma Inc.; Bavarian Nordic A/S; Bharat Biotech International Ltd.; Biological E Limited; Boehringer Ingelheim International GmbH; CanSino Biologics Inc.; CSL Limited; Daiichi Sankyo Company, Limited; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Hualan Biological Engineering Inc.; Inovio Pharmaceuticals, Inc.; Johnson & Johnson Services Inc.; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation; Novartis AG; Novavax, Inc.; Pfizer Inc.; Sanofi Pasteur; Serum Institute of India Pvt. Ltd.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Inactivated Vaccines – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 36 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Global Emphasis on Routine Immunization Programs Drives Demand for Inactivated Vaccines

Increased Preference for Well-Established Vaccine Technologies Supports Market Stability Amid Emerging Threats

Global Shift Away From Live Vaccines in Immunocompromised Populations Strengthens Case for Inactivated Platforms

Surge in Demand for Safe, Scalable Vaccine Production Platforms Accelerates Adoption of Inactivated Formulations

Regulatory Endorsement of Inactivated Vaccines for Pediatric and Elderly Populations Expands Application Scope

Growing Public Trust in Inactivated Vaccines Amid Vaccine Hesitancy Supports Uptake in Developed Markets

Expansion of Travel Medicine and Pre-Exposure Vaccination Drives Market for Inactivated Viral and Bacterial Vaccines

WHO and GAVI Support for Inactivated Vaccine Procurement in LMICs Fuels Global Immunization Equity

R&D Investments in Adjuvant Technologies Improve Immunogenicity and Dosing Efficiency of Inactivated Vaccines

Use of Inactivated Platforms in Combination and Multivalent Vaccines Enhances Pediatric Coverage and Compliance

Rising Demand for Thermostable Vaccine Formulations Boosts Development of Heat-Resistant Inactivated Products

Emergence of Pandemic and Outbreak Scenarios Repositions Inactivated Vaccines as Rapid-Response Tools

4. GLOBAL MARKET PERSPECTIVE

World Inactivated Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Viral Vaccine Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Viral Vaccine Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Viral Vaccine Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Bacterial Vaccine Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Bacterial Vaccine Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Bacterial Vaccine Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Specialty Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Specialty Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Specialty Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Homecare Settings End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Homecare Settings End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Homecare Settings End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Solvent Detergent Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Solvent Detergent Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Solvent Detergent Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Radiation Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Radiation Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Radiation Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for pH Concentration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for pH Concentration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for pH Concentration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Inactivation Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Inactivation Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Inactivation Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Subcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Intravenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

JAPAN

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

CHINA

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

EUROPE

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Inactivated Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

FRANCE

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

GERMANY

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

UNITED KINGDOM

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Inactivated Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

AUSTRALIA

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

INDIA

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

LATIN AMERICA

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Inactivated Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

MIDDLE EAST

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Inactivated Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

AFRICA

Inactivated Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Inactivated Vaccines by Vaccine Type - Viral Vaccine Type and Bacterial Vaccine Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Inactivated Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Viral Vaccine Type and Bacterial Vaccine Type for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Inactivated Vaccines by End-user - Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Inactivated Vaccines by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Specialty Clinics End-User, Homecare Settings End-User and Other End-Users for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Inactivated Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Inactivated Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration and Other Inactivation Methods for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Inactivated Vaccines by Administration Route - Oral, Subcutaneous and Intravenous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Inactivated Vaccines by Administration Route - Percentage Breakdown of Value Sales for Oral, Subcutaneous and Intravenous for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll